CAL-PHOS SUSPENSION- calcium glycerophosphate and calcium lactate liquid 
Radix Laboratories, Inc.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

CAL-PHOS SUSPENSION

CONTENTS (per ml):

  • Calcium Glycerophosphate .............50mg
  • Calcium Lactate ..............................50mg

Inactives:

  • Purified Water  q.s.
  • Inactives: Methylparaben, Propylparaben

Indications:

  • For use as a supplemental source of calcium and phosphorus for cattle, swine, sheep, dogs, and cats.

Storage:

  • Store at controlled room temperature between 59oF to 86oF (15oC -30oC).

Warnings:

  • SHAKE WELL BEFORE USAGE.
  • Administer with care to avoid aspiration.

Dosage and administration:

  • Administer orally as a drench or by use of a stomach tube.
  • Large animals: 150mL (5 fl. oz.) to 250mL (8 fl. oz.) twice daily for 3 days.
  • Small animals: 2 to 5 mL per # of body weight twice daily for 3 days.
  • Do not overdose.

  • Keep away from children.
  • FOR ANIMAL USE ONLY

CAL-PHOS PRINCIPAL DISPLAY PANEL

Principal Display Panel
CAL-PHOS SUSPENSION 
cal-phos suspension liquid
Product Information
Product TypeOTC ANIMAL DRUG LABELItem Code (Source)NDC:50480-137
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CALCIUM GLYCEROPHOSPHATE (CALCIUM CATION) CALCIUM GLYCEROPHOSPHATE12.5 g  in 250 mL
CALCIUM LACTATE (CALCIUM CATION) CALCIUM LACTATE12.5 g  in 250 mL
Product Characteristics
Color    Score    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:50480-137-2512 in 1 CARTON
1250 mL in 1 BOTTLE, PLASTIC
Image of Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other09/27/2013
Labeler - Radix Laboratories, Inc. (108500091)

Revised: 1/2014
 
Radix Laboratories, Inc.